EFFICACY IN CLEARING NGS-MRDAND SHORT-TERM PROGNOSIS OF 14-DAY VERSUS 28-DAY BLINATUMOMAB IN PEDIATRIC B-ALL

EHA Library, YingJin Zhang, 4161443

THE INCIDENCE OF OBESITY AND METABOLIC SYNDROME DEVELOPMENT IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER COMPLETING TREATMENT

EHA Library, Adalet Meral Güneş, 4161444

OUTCOMES WITH PRETRANSPLANT BLINATUMOMAB FOLLOWED BY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION WITH PTCY FOR B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Noah Merin, 4161445

FIRST-LINE (1L) AND SECOND-LINE (2L) TREATMENT PATTERNS IN PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN DIFFERENT TIME PERIODS

EHA Library, Nikesh Shah, 4161446

LABORATORY EVALUATION, CLINICAL FEATURES, AND PROGNOSTIC ANALYSIS OF ACUTE LEUKEMIA WITH TAF15::ZNF384 FUSION GENE

EHA Library, Zheng Wang, 4161447

A QUALITY-ADJUSTED SURVIVAL ANALYSIS IN ADULT AND ELDERLY PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: COMPARING REDUCED-INTENSITY AND FULL-DOSE CHEMOTHERAPY REGIMENS

EHA Library, Fausto Alfredo Rios-Olais, 4161448

SPATIOTEMPORAL DISTRIBUTION AND SOCIOECONOMIC DETERMINANTS OF REGIONAL DISPARITIES IN LYMPHOID LEUKEMIA MORTALITY AMONG CHILDREN AND ADOLESCENTS IN BRAZIL: AN ECOLOGICAL STUDY

EHA Library, Bárbara Sarni Sanches, 4161449

ASSOCIATION OF FOXO3 (RS17069665) GENE POLYMORPHISM AND CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN EGYPT

EHA Library, Samar Elbahy, 4161450

PROGNOSTIC FACTORS AND OUTCOMES OF ADULT PATIENTS WITH MIXED PHENOTYPE ACUTE LEUKEMIA: A SINGLE-CENTER EXPERIENCE

EHA Library, Mirjana Cvetkovic, 4161451

OUTCOMES OF HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER INOTUZUMAB OZOGAMICIN TREATMENT FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITHOUT VOD/SOS

EHA Library, Weihua Zhai, 4161452

SYSTEMATIC FLOW CYTOMETRY ANALYSIS REFINES THE DETECTION OF CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Lena Veauvy, 4161453

ANALYSIS OF CLINICAL AND LABORATORY CHARACTERISTICS OF ALL WITH ATYPICAL BCR::ABL1 FUSION GENES

EHA Library, Yanbo Nie, 4161454

DETERMINANTS OF SURVIVAL IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: A DECADE OF EXPERIENCE IN NORTHEASTERN COLOMBIA

EHA Library, Luis Sossa-Pinzón, 4161455

DIAGNOSTIC AND PROGNOSTIC VALUES OF NCF4 RS1883112 POLYMORPHISM EXPRESSION AMONG ACUTE LYMPHOBLASTIC LEUKEMIA IN EGYPTIAN CHILDREN

EHA Library, Samar Elbahy, 4161456

CLINICAL CHARACTERISTICS AND OVERALL SURVIVAL OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA. A STUDY FROM THE GRELAL-CHILE EPIDEMIOLOGIC REGISTRY.

EHA Library, Yorman Flores, 4161457

ALTERNATING LOW-DOSE INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB IN MAINTENANCE THERAPY FOR PH+ALL: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Zi-Yuan Nie, 4161458

LONG-TERM FOLLOW UP OF PEDIATRIC PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH TYROSINE KINASE INHIBITORS PLUS CHEMOTHERAPY

EHA Library, Nour Siala, 4161459

UNRAVELING THE UNIQUE CLINICAL AND LABORATORY FEATURES OF BCR::FGFR1 EMS: A FOUR CASES STUDY AND LITERATURE REVIEW

EHA Library, Shaobin Yang, 4161460

TREATMENT OF PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA:OUTCOMES IN ADOLESCENTS AND YOUNG ADULTS

EHA Library, Aya Ben Othmen, 4161461

ACUTE TOXICITIES DURING INDUCTION AND FIRST CONSOLIDATION TREATMENT OF YOUNG ADULTS WITH ALL: COMPARISON OF ALL CELL 2023 JUNIOR AND GMALL 07/2003 PROTOCOLS - A SINGLE CENTER EXPERIENCE

EHA Library, Jana Vedrova, 4161462

RESULTS OF TREATMENT OF PH-NEGATIVE MIXED PHENOTYPE ACUTE LEUKEMIA ACCORDING TO THE PROTOCOLS OF THE RUSSIAN RESEARCH GROUP ON ACUTE LYMPHOBLASTIC LEUKEMIA TREATMENT.

EHA Library, Djamilya Bytdaeva, 4161463

THE ROLE OF IRON IN THE PROCESSES OF HEMATOPOIESIS RECOVERY DURING TREATMENT IN CHILDREN WITH ALL, RESIDENTS OF RADIOACTIVELY CONTAMINATED TERRITORIES OF UKRAINE

EHA Library, Katerine Bruslova, 4161464

REAL-WORLD DATA ON INOTUZUMAB OZOGAMICIN FOR ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: A GRELAL-CHILE STUDY

EHA Library, Natalia Aranguiz, 4161465

OVERALL AND DISEASE-FREE SURVIVAL AT 1 AND 5 YEARS IN ADULT PATIENTS WITH ACUTE LYMPHOID LEUKEMIA, TREATED WITH TWO INDUCTION CHEMOTHERAPY REGIMENS, IN A CANCER CENTER IN THE CITY OF BOGOTÁ, 2013 - 2020

EHA Library, Carlos Bermudez Silva, 4161466

ZHIGANCAO DECOCTION IMPROVE DOXORUBICIN-INDUCED MYOCARDIAL APOPTOSIS THROUGH REGULATING MIR-21/TLR4 PATHWAY VIA THE METTL3-MEDIATED M6A RNA METHYLATION

EHA Library, Xing Cui, 4161467

PHILADELPHIA-CHROMOSOME POSITIVE B ACUTE LYMPHOBLASTIC LEUKEMIA : CLINICAL, PROGNOSTIC AND THERAPEUTIC PROFILE

EHA Library, Wiem Chaaouri, 4161468

EFFICACY OF VENETOCLAX COMBINED WITH CHEMOTHERAPY IN RELAPSED/REFRACTORY OR ELDERLY ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA

EHA Library, Zhenjiang Li, 4161469

ACUTE LYMPHOBLASTIC LEUKEMIA,REAL-TIME DATA IN THE LAST FIVE YEARS IN ALBANIA(2019-2023)

EHA Library, Elda Dhelpra, 4161470

BLINATUMOMAB IN PRACTICE FOR ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS

EHA Library, Gaixiang Xu, 4161471

IMPACT OF BLINATUMOMAB ON OVERALL SURVIVAL IN RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: INSIGHTS FROM A HEMATOLOGY CENTER IN COLOMBIA

EHA Library, Luis Sossa-Pinzón, 4161472

FRONTLINE QUADRUPLET THERAPY IN THE CEREBROSPINAL FLUID (CSF) AT THE FIRST RELAPSE IN THE CENTRAL NERVOUS SYSTEM (CNS) IN B CELL MALIGNANCIES

EHA Library, Maher Salamoon, 4161473

Successful treatment of skin injury caused by high dose methotrexate with calcium folinate wet compress: a case report

EHA Library, Hengrui Sun, 4161474

SAFETY AND EFFICACY OF MITOXANTRONE HYDROCHLORIDE LIPOSOME INJECTION COMBINED WITH LOW-DOSE CYTARABINE IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER STUDY

EHA Library, xi Huang, 4161475

CLINICAL CHARACTERISTICS ANALYSIS OF THREE PEDIATRIC B-ALL CASES WITH MYC REARRANGEMENT

EHA Library, Yuehui Lin, 4161476

BLINATUMOMAB IN CD19 POSITIVE PRECURSOR B-CELL ALL PHILADELPHIA NEGATIVE DISEASE USED TO PURGE BONE MARROW AFTER THE END OF INDUCTION IN PATIENTS DEMONSTRATING RESIDUAL BONE MARROW DISEASE: THE IMPACT ON PROGRESSION FREE SURVIVAL

EHA Library, Maher Salamoon, 4161477

ANALYSIS OF CLINICAL CHARACTERISTICS AND PROGNOSIS IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Tao Wu, 4161478

NURSING CARE OF HOME-BASED BELLINTUZUMAB THERAPY IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA—— A SINGLE-CENTER STUDY FROM CHINA

EHA Library, Chunli Wang, 4161479

A PHASE 1B OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF EGANELISIB AS MONOTHERAPY AND IN COMBINATION WITH CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Marie Payton, 4161480

THE MECHANISM OF PARP INHIBITOR ENHANCE DECITABINE FUNCTION IN TET2-DEFICIENT MYELOID LEUKEMIA

EHA Library, Shijie Yang, 4161482

FLT3 INHIBITORS MIDOSTAURIN AND GILTERITINIB ENHANCE CYTARABINE ACCUMULATION BY AFFECTING OCTN1 AND ENT1 TRANSPORTERS IN AML CELLS

EHA Library, Simona Dudičová, 4161483

ANALYSIS OF ALTERNATIVE THERAPEUTIC OPTIONS FOR ACUTE MYELOID LEUKEMIA PATIENTS RESISTANT TO VENETOCLAX BASED ON DRUG SCREENING AND EXPRESSION PROFILING

EHA Library, Filio Stylianou, 4161484

FUNCTIONAL CHARACTERISTICS AND CLINICAL IMPLICATIONS OF CD39-EXPRESSING T CELL POPULATIONS IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Yoon Seok Choi, 4161485

HUMAN PAPILLOMA VIRUS DNA POSITIVE HEMOPOIETIC MALIGNANCIES- CLINICAL AND MOLECULAR FEATURES.

EHA Library, Gustavo Rivero, 4161486

SHOULD IDH2 P.R172 ACUTE MYELOID LEUKEMIA BE CONSIDERED AS A DISTINCT ENTITY WITH FAVORABLE PROGNOSIS?

EHA Library, Pau Montesinos, 4161487

SYNTHETIC DATA GENERATION AND VALIDATION FOR AML

EHA Library, Adriano Zaghi, 4161488

PEVONEDISTAT INDUCES APOPTOSIS OF ACUTE MYELOID LEUKEMIA CELLS THROUGH ROS-MEDIATED UPREGULATION OF EGR1 EXPRESSION

EHA Library, Xiao Tang, 4161489

8-CHLORO-ADENOSINE COMBINED WITH HOMOHARRINGTONINE INDUCES FERROPTOSIS IN FLT3-ITD-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Liping Xu, 4161490

THE TIP39-PTH2R AXIS REDUCES MTOR EXPRESSION AND INDUCES AUTOPHAGY IN MYELOID LEUKEMIC CELLS.

EHA Library, Hiroto Horiguchi, 4161491

TARGETING IFNα PATHWAY RESTORES PML NUCLEAR BODIES FORMATION IN TBLR1-RARA-DRIVEN PROMYELOCYTIC LEUKEMIA IN THE CONTEXT OF ATRA AND ATO UNRESPONSIVENESS

EHA Library, xue yang, 4161492

TARGETING CDK2 INDUCES ACUTE MYELOID LEUKEMIA DIFFERENTIATION BY DECREASING THE TRANSCRIPTION OF C-MYC AND ZFP36L2 THROUGH INHIBITION OF P300-MEDIATED H3K27 ACETYLATION

EHA Library, Yi Chen, 4161493

PROGNOSTIC IMPORTANCE OF FLT3-ITD IN DIFFERENT CYTOGENETIC AND MOLECULAR-GENETIC SUBGROUPS OF PEDIATRIC AML

EHA Library, Vanessa Bankole, 4161494

INTEGRATED GENOMIC AND TRANSCRIPTOMIC ANALYSIS FOR DISEASE CLASSIFICATION, RISK STRATIFICATION, AND TARGET DISCOVERY OF HUMAN AML

EHA Library, Lanpeng Chen, 4161495

INTEGRATION OF RNA-SEQ IN SYNTHETIC DATA GENERATION ENHANCES SUBGROUP ANALYSIS, ENABLING ADVANCED COMPUTATIONAL ANALYSES

EHA Library, Matteo Caridi, 4161496

DUAL PATHWAY TARGETING IN AML: BMP INHIBITION FOR DE NOVO DISEASE AND ERK INHIBITION FOR THERAPY-RESISTANCE

EHA Library, Bithiah Grace Jaganathan, 4161497

AUTOPHAGY INHIBITION BOOSTS MIDOSTAURIN'S EFFICACY AGAINST FLT3-MUTATED LEUKEMIC STEM CELLS UNDER CONDITIONS MIMICKING THE HYPOXIC BONE MERROW MICROENVIRONMENT.

EHA Library, Samantha Bruno, 4161498

ACUTE MYELOID LEUKAEMIA DRIVES CHANGES IN MEGAKARYOCYTE POPULATION IN THE LUNG

EHA Library, Aaron White, 4161499

ANALYSIS OF PML::RARA ISOFORMS, SEQUENCE CHARACTERISTICS OF VARIANT TRANSCRIPTS, AND IMPROVEMENTS IN QUANTITATIVE PCR DETECTION METHODS

EHA Library, Xiaoli Ma, 4161500

UNC93B1 PROMOTES VENETOCLAX RESISTANCE IN ACUTE MYELOID LEUKAEMIA VIA ENHANCED GLUCOSE METABOLISM

EHA Library, bobin su, 4161502

AN IN-VIVO MURINE CRISPR-CAS9 SCREENING IDENTIFIES NOVEL REGULATORS OF ACUTE MYELOID LEUKEMIA

EHA Library, Alan Huguenin, 4161503

MOLECULAR LANDSCAPE OF ACUTE MYELOID LEUKEMIA: A COMPREHENSIVE ANALYSIS FROM ATERTIARY CENTRE IN INDIA

EHA Library, Thejeswar N Prakasham, 4161504

PROGNOSTIC VALUE AND MECHANISMS OF METTL17 IN ACUTE MYELOID LEUKEMIA

EHA Library, Siyuan Cui, 4161505

PERTURBATIONS OF ANTIOXIDANT METABOLISM REVEAL REDOX-REGULATED PATHWAYS ESTABLISHING SURVIVAL REQUIREMENTS AND VULNERABILITIES OF AML

EHA Library, Dušan Němec, 4161506

IDENTIFICATION OF CELLULAR MECHANISMS THAT CAN LEAD TO DRUG RESISTANCE TO FLT3 INHIBITOR GILTERITINIB IN AML

EHA Library, Martina Ceckova, 4161507

REALGAR-INDIGO NATURALIS FORMULA (RIF): A NOVEL STRATEGY TO OVERCOME ARSENIC RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Li Hou, 4161508

POTENTIATION OF RETINOID-INDUCED DIFFERENTIATION IN ACUTE MYELOID LEUKEMIA CELLS VIA NRF2 ACTIVATION

EHA Library, Haimantika Seel, 4161509

MECHANISM OF A NOVEL COMPLEX: ZNO-LUTEOLIN NANOPARTICLES TO PROMOTE FERROPTOSIS IN HUMAN ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Zonghong Li, 4161510

NOVEL LGALS1 INHIBITOR COMBINED WITH VENETOCLAX SYNERGISTICALLY KILLS ACUTE MYELOID LEUKAEMIA CELLS

EHA Library, bobin su, 4161511

PLZF::RARα FUSION PROTEIN DISRUPTS ANTIOXIDANT AND MITOCHONDRIAL HOMEOSTASIS IN ACUTE PROMYELOCYTIC LEUKEMIA: INSIGHTS INTO NOVEL THERAPEUTIC APPROACHES

EHA Library, Alessandra Zaza, 4161512

SELINEXOR SYNERGISTICALLY PROMOTES THE ANTILEUKEMIA ACTIVITY OF AVAPRITINIB IN ACUTE MYELOID CELLS (AML) WITH AML1-ETO AND KIT MUTATION BY TARGETING PLK1 SIGNALING AND E2F SIGNALING

EHA Library, Liang-In Lin, 4161513

THE AML MUTANT QUARTET: DISSECTING THE TRANSCRIPTIONAL EFFECTS OF FLT3-ITD WITH ALKBH5-KO AND TET2 AND IDH2 MUTATIONS IN HEMATOPOIETIC PRECURSORS

EHA Library, Alessandro Pilli, 4161514

STUDY OF METABOLIC POLYMORPHISMS AS PREDICTORS OF CYTARABINE TOXICITY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Anna Sicuranza, 4161515

IMMUNOPHENOTYPIC AND IMMUNOTRANSCRIPTOMIC CHARACTERIZATION REVEALS DIFFERENTIAL ACUTE MYELOGENOUS LEUKEMIA LIPIDOMIC DEPENDENCIES.

EHA Library, Gustavo Rivero, 4161517

THE ROLE OF KRIT IN HEMATOLOGICAL DISEASES: MODULATION AND RESPONSE TO CLINICAL TREATMENTS

EHA Library, Cristina Panuzzo, 4161518

EVALUATION OF NOVEL STRUCTURES AS POTENTIAL FLT3 INHIBITORS IN AML

EHA Library, Jan Rataj, 4161519

FACTORS PREDICTING MYELODYSPLASTIC SYNDROME (MDS) TRANSFORMATION TO ACUTE MYELOGENOUS LEUKEMIA (AML), GENETIC DEFECTS AND CHROMOSOMAL ABNORMALIES

EHA Library, Maher Salamoon, 4161520

RETROSPECTIVE ANALYSIS OF OUTCOMES OF SHORTER COURSE OF VENETOCLAX WITH HYPOMETHYLATING AGENT IN NEWLY DIAGNOSED PATIENTS OF AML - SINGLE CENTRE EXPERIENCE

EHA Library, Bhavani Mandava, 4161521

TAILORING THE MOLECULAR PATTERN OF ACUTE MYELOID LEUKEMIA WITH EXTRAMEDULLARY INVOLVEMENT (EM-AML) UNVEILS THE PIVOTAL ROLE OF MESENCHYMAL STROMAL CELLS (MSCS) IN SUPPORTING DISEASE PROGRESSION

EHA Library, Giorgia Silvestrini, 4161522

HYPOXIA SUPPORTS INFLAMMATION-MEDIATED ENDOTHELIAL CELL ACTIVATION IN AML

EHA Library, Nikola Pantic, 4161523

THERAPEUTIC POTENTIAL OF NIRAPARIB, CCT245737, AND CONVENTIONAL THERAPY COMBINATIONS IN ACUTE MYELOBLASTIC LEUKEMIA: A PRELIMINARY IN VITRO STUDY

EHA Library, Ana Bela Sarmento-Ribeiro, 4161524

REALGAR-INDIGO NATURALIS FORMULA EXERTS AN ANTI-TUMOR EFFECT IN TUMOR-BEARING NUDE MICE BY ENHANCING THE AUTOPHAGY LEVEL TO PROMOTE THE APOPTOSIS OF ARSENIC-RESISTANT TUMOR CELLS.

EHA Library, Li Hou, 4161525

MULTIDRUG RESISTANCE AND METABOLIC REPROGRAMMING IN FLT3 MUTANT AML FOLLOWING PROLONGED FLT3 INHIBITOR TREATMENT

EHA Library, Lívia Bassani Lins de Miranda, 4161526

EPIGENETIC PERTURBATION OF PEDIATRIC AND ADULT ACUTE MYELOID LEUKEMIA AS A NEW APPROACH TO TARGET LEUKEMIC STEM CELLS

EHA Library, Cecilia Reyneri, 4161527

DETERMINING THE INVOLVEMENT OF THE HEDGEHOG SIGNALING PATHWAY IN THE DEVELOPMENT OF RESISTANCE AGAINST VENETOCLAX IN ACUTE MYELOID LEUKEMIA

EHA Library, Hager Abouelnaga, 4161528

COPY NEUTRAL LOH OF KITLG GENE IS ASSOCIATED WITH A LOWER REMISSION RATE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA.

EHA Library, Dmitry Bessmertniy, 4161529

INVESTIGATING BCL2 EXPRESSION VIA IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSY AS A PROGNOSTIC MARKER FOR RESPONSE OF ACUTE MYELOID LEUKAEMIA TO VENETOCLAX

EHA Library, Zainab Ridha, 4161530

CRUCIAL ROLE OF NEXT GENERATION SEQUENCING IN THE PROGNOSTIC RECLASSIFICATION OF INTERMEDIATE-RISK ACUTE MYELOID LEUKEMIAS: THE SIENA HEMATOLOGY EXPERIENCE

EHA Library, Anna Sicuranza, 4161531

ACQUIRED FACTOR VII DEFICIENCY (AFVIID) ASSOCIATED WITH ACUTR LEUKEMIA (AL), A CASE SERIES FROM MONASTIR, TUNISIA

EHA Library, Ahlem Slama, 4161532

DECODING RTK-RAS SIGNALING IN AML: FROM GENETIC ALTERATIONS TO POTENTIAL THERAPEUTIC TARGETS

EHA Library, Pranay Tanwar, 4161533

FERULIC ACID ATTENUATES PROLIFERATION VIA MAPK/ERK PATHWAY IN ACUTE MYELOID LEUKEMIA

EHA Library, Chengling Zhang, 4161534

CLADRIBINE AS POTENTIAL PERSONALIZED TREATMENT FOR IDH1/2-MUTANT AML - AN IN SILICO INVESTIGATION

EHA Library, Zuzanna Nowicka, 4161536

INTEREST OF IMMATURE FRACTION OF RETICULOCYTES IN THE MONITORIONG OF HEMATOLOGICAL RECOVERY POST-CHEMOTHERAPY IN CANCER PATIENTS

EHA Library, Amine Moueden, 4161537

CXCR4 EXPRESSION ON LEUKEMIC BLASTS OF AML PATIENTS IN PERIPHERAL BLOOD AND BONE MARROW: IMPACT OF CRYOPRESERVATION AND GENETIC CORRELATIONS

EHA Library, Andreas Rank, 4161538

DNA DAMAGE RESPONSE GENE EXPRESSION ANALYSIS IN ELDERLY AML PATIENTS TREATED WITH HMAS AND VENETOCLAX.

EHA Library, Agni Vitsioti, 4161539

ACUTE MEGAKARYOBLASTIC LEUKEMIA LAMK: A CASE REPORT FROM THE HÔPITAL MILITAIRE D'INSTRUCTION MOHAMMED V (HMIMV)

EHA Library, Nadia Bennai, 4161540

IDENTIFICATION OF IMMUNE MODULATORS OF CAR-T CELLS TARGETING CD33 IN ACUTE MYELOID LEUKEMIA

EHA Library, Hugo Legenne, 4161541

STUDY OF MOLECULAR AND CLINICAL PROFILE OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA AND ITS OUTCOME

EHA Library, Omkar Choudhari, 4161542

AMINO ACID METABOLIC ADAPTATIONS IN AML: INSIGHTS FROM NOVEL PEGCRISANTASPASE AND VENETOCLAX THERAPY

EHA Library, Ashkan Emadi, 4161543

ANTI-TUMOR ACTIVITY AND RESTORATION OF HEMATOPOIESIS ACHIEVED WITH TAGRAXOFUSP IN PATIENTS WITH TREATMENT-NAÏVE BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN): PIVOTAL TRIAL SUBANALYSIS

EHA Library, Marina Konopleva, 4161544

SUBGROUP ANALYSIS BY FITNESS CRITERIA OF PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH FIRST-LINE TAGRAXOFUSP

EHA Library, Naveen Pemmaraju, 4161545

IMPROVED TREATMENT OUTCOMES WITH CLADRIBINE, IDARUBICIN, CYTARABINE, AND VENETOCLAX (CLIA-VEN) OVER CONVENTIONAL 7+3 CHEMOTHERAPY IN DE NOVO ACUTE MYELOID LEUKEMIA

EHA Library, Kiran Naqvi, 4161546